Lumexa Imaging Holdings, Inc. (LMRI) Stock Forecast
LMRI analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.80 / 5 from 10 analysts
- Price target
- $17.67 average of analyst targets
- Upside to target
- +63.9% from the latest close
- Next earnings
- November 11, 2026 EPS estimate $0.07
- 52-week range
- $6.77 – $18.53
LMRI analyst ratings
10 analystsNumber of analysts at each rating.
LMRI price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
LMRI earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.18 | $0.16 | $0.22 | — | — | 8 |
| Current fiscal year (2026) | $0.77 | $0.73 | $0.84 | $0.18 | +326.5% | 8 |
| Next fiscal year (2027) | $0.89 | $0.80 | $1.00 | $0.77 | +16.2% | 8 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
LMRI revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $269.9M | $264.9M | $276.5M | — | 9 |
| Current fiscal year (2026) | $1.07B | $1.05B | $1.08B | +4.3% | 9 |
| Next fiscal year (2027) | $1.12B | $1.11B | $1.14B | +5.4% | 9 |
LMRI EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
LMRI revenue: reported and forecast
LMRI EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.19 | $0.19 | $0.19 | $0.18 | $0.18 | −5.2% | 1 up · 2 down |
| Current fiscal year (2026) | $0.71 | $0.71 | $0.77 | $0.77 | $0.77 | +8.5% | 4 up · 0 down |
| Next fiscal year (2027) | $0.90 | $0.90 | $0.91 | $0.89 | $0.89 | −1.1% | 3 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
LMRI earnings surprises
Reported EPS vs the consensus estimate for the last 4 quarters; LMRI beat in 1 of 4.
What analysts expect from LMRI
10 analysts cover Lumexa Imaging; their consensus rating is strong buy (4.80 on a 1–5 scale, where 5 is a strong buy). The average price target is $17.67, 63.9% above the latest close of $10.78. Analysts expect earnings of $0.77 per share for 2026, +326.5% from a year earlier. For 2027 the average estimate is $0.89 per share on revenue of $1.1 billion. Lumexa Imaging beat the EPS estimate in 1 of the last 4 quarters.
Related: LMRI income statement, LMRI key metrics, LMRI chart. See the LMRI stock overview for the latest quote and news.
LMRI forecast FAQ
What is Lumexa Imaging's price target?
The average analyst price target for Lumexa Imaging is $17.67, 63.9% above the latest close of $10.78.
Is Lumexa Imaging a buy, hold or sell?
Of 10 analysts covering Lumexa Imaging, 8 rate it a strong buy, 2 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Lumexa Imaging's EPS forecast?
Analysts forecast $0.77 per share for 2026 (range $0.73 to $0.84); for 2027 the estimate is $0.89.
What is Lumexa Imaging's revenue forecast?
The average revenue estimate for 2026 is $1.1 billion, growth of 4.3%; for 2027 it is $1.1 billion.
When does Lumexa Imaging report earnings?
Lumexa Imaging is expected to report results for the quarter ending September 30, 2026 on November 11, 2026; the EPS estimate is $0.07.
Does Lumexa Imaging usually beat earnings estimates?
Lumexa Imaging reported EPS at or above the analyst estimate in 1 of the last 4 quarters.